2017
Association of Panic Disorder, Generalized Anxiety Disorder, and Benzodiazepine Treatment During Pregnancy With Risk of Adverse Birth Outcomes
Yonkers KA, Gilstad-Hayden K, Forray A, Lipkind HS. Association of Panic Disorder, Generalized Anxiety Disorder, and Benzodiazepine Treatment During Pregnancy With Risk of Adverse Birth Outcomes. JAMA Psychiatry 2017, 74: 1145-1152. PMID: 28903165, PMCID: PMC5710298, DOI: 10.1001/jamapsychiatry.2017.2733.Peer-Reviewed Original ResearchConceptsSerotonin reuptake inhibitor useAdverse birth outcomesLow birth weightSerotonin reuptake inhibitorsWeeks of pregnancyHypertensive diseaseDuration of gestationRespiratory interventionsVentilatory supportCesarean deliveryReuptake inhibitorsPanic disorderPregnancy outcomesInhibitor usePreterm birthBirth outcomesBenzodiazepine treatmentBirth weightAnxiety disordersWorld Mental Health Composite International Diagnostic InterviewPrevious adverse birth outcomesComposite International Diagnostic InterviewAdverse pregnancy complicationsMaternal panic disorderNeonatal pregnancy outcomes
2014
Pregnant Women With Posttraumatic Stress Disorder and Risk of Preterm Birth
Yonkers KA, Smith MV, Forray A, Epperson CN, Costello D, Lin H, Belanger K. Pregnant Women With Posttraumatic Stress Disorder and Risk of Preterm Birth. JAMA Psychiatry 2014, 71: 897-904. PMID: 24920287, PMCID: PMC4134929, DOI: 10.1001/jamapsychiatry.2014.558.Peer-Reviewed Original ResearchConceptsMajor depressive episodePosttraumatic stress disorderPreterm birthWeeks of pregnancyPregnant womenDepressive episodeModified PTSD Symptom ScalePTSD Symptom ScaleStress disorderBenzodiazepine medicationLikely diagnosisSymptom ScaleComposite International Diagnostic InterviewProspective cohort studySerotonin reuptake inhibitorsLogistic regression analysisCohort studyMedication useReuptake inhibitorsBenzodiazepine treatmentBenzodiazepine usePsychotropic treatmentObstetrical practicePsychiatric illnessAnxiolytic treatment
2013
ISPMD consensus on the management of premenstrual disorders
Nevatte T, O’Brien P, Bäckström T, Brown C, Dennerstein L, Endicott J, Epperson CN, Eriksson E, Freeman EW, Halbreich U, Ismail K, Panay N, Pearlstein T, Rapkin A, Reid R, Rubinow D, Schmidt P, Steiner M, Studd J, Sundström-Poromaa I, Yonkers K, Consensus Group of the International Society for Premenstrual Disorders. ISPMD consensus on the management of premenstrual disorders. Archives Of Women's Mental Health 2013, 16: 279-291. PMID: 23624686, PMCID: PMC3955202, DOI: 10.1007/s00737-013-0346-y.Peer-Reviewed Original ResearchConceptsPremenstrual disordersGonadotropin-releasing hormone agonistSelective serotonin reuptake inhibitorsRole of oophorectomySecond consensus meetingSerotonin reuptake inhibitorsVitex agnus castusCentral nervous activityCognitive behavioral therapySuppress ovulationOral contraceptivesOvulation suppressionReuptake inhibitorsHormone agonistPsychotropic medicationsCalcium supplementsAlternative therapiesConsensus recommendationsSex steroidsConsensus meetingNervous activityConsensus conferenceCareful diagnosisBehavioral therapyAgnus castus
2012
Depression and Serotonin Reuptake Inhibitor Treatment as Risk Factors for Preterm Birth
Yonkers KA, Norwitz ER, Smith MV, Lockwood CJ, Gotman N, Luchansky E, Lin H, Belanger K. Depression and Serotonin Reuptake Inhibitor Treatment as Risk Factors for Preterm Birth. Epidemiology 2012, 23: 677-685. PMID: 22627901, PMCID: PMC3415566, DOI: 10.1097/ede.0b013e31825838e9.Peer-Reviewed Original ResearchConceptsSerotonin reuptake inhibitorsMajor depressive episodePreterm birthDepressive episodeLogistic regressionSRI useUse of SRIsSerotonin reuptake inhibitor treatmentReuptake inhibitor treatmentEarly preterm birthLate preterm birthProspective cohort studyPreterm birth riskMajor depressive disorderNominal logistic regressionBinary logistic regressionAntidepressant treatmentCohort studyHospital chartsReuptake inhibitorsSymptomatic womenBirth outcomesPregnant womenRisk factorsDepressive disorder
2008
Premenstrual syndrome
Yonkers KA, O'Brien P, Eriksson E. Premenstrual syndrome. The Lancet 2008, 371: 1200-1210. PMID: 18395582, PMCID: PMC3118460, DOI: 10.1016/s0140-6736(08)60527-9.Peer-Reviewed Original ResearchConceptsSevere premenstrual syndromePremenstrual dysphoric disorderPremenstrual syndromeSerotonin reuptake inhibitorsGonadal hormone levelsGonadotropin-releasing hormoneOral contraceptivesReuptake inhibitorsBreast tendernessSerotonergic synapsesReproductive ageHormone levelsDysphoric disorderLuteal phaseOvary axisMost womenOvarian cyclicityBehavioral symptomsDepressed moodSymptomsMood swingsSomatic complaintsPhysical discomfortWomenDaily activities
2003
Premenstrual disorders: bridging research and clinical reality
Yonkers KA, Pearlstein T, Rosenheck RA. Premenstrual disorders: bridging research and clinical reality. Archives Of Women's Mental Health 2003, 6: 287-292. PMID: 14628181, DOI: 10.1007/s00737-003-0026-4.Peer-Reviewed Original ResearchMeSH KeywordsAdultConnecticutDepressive DisorderDiagnostic and Statistical Manual of Mental DisordersFemaleHumansPatient Acceptance of Health CarePatient SelectionPremenstrual SyndromePsychiatric Status Rating ScalesSelective Serotonin Reuptake InhibitorsSelf-AssessmentSeverity of Illness IndexSurveys and QuestionnairesTreatment OutcomeConceptsPremenstrual dysphoric disorderPremenstrual symptomsTreatment resultsBrief Patient Health QuestionnaireConcurrent psychiatric conditionsOb-gyn settingsStatistical Manual IV criteriaSerotonin reuptake inhibitorsUsual care settingsPatient Health QuestionnaireMinor depressive disorderActual clinical practiceTypes of symptomsEligible womenPatient characteristicsReuptake inhibitorsOpen trialSymptomatic subgroupCurrent comorbidityIV criteriaClinical trialsDepressive disorderHealth QuestionnaireTypical patientDysphoric disorder